GI
BNTX icon

GAMMA Investing’s BioNTech BNTX Stock Holding History

GAMMA Investing’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$64K Buy
651
+80
+14% +$7.77K ﹤0.01% 2201
2026
Q2 		$53.1K Buy
571
+15
+3% +$1.41K ﹤0.01% 2253
2026
Q1 		$49.4K Sell
556
-50
-8% -$5.14K ﹤0.01% 2190
2025
Q4 		$57.7K Sell
606
-178
-23% -$17.9K ﹤0.01% 1979
2025
Q3 		$77.3K Buy
784
+227
+41% +$24.3K ﹤0.01% 1696
2025
Q2 		$59.3K Sell
557
-32
-5% -$3.23K ﹤0.01% 1820
2025
Q1 		$53.6K Sell
589
-334
-36% -$37.4K ﹤0.01% 1740
2024
Q4 		$105K Buy
923
+300
+48% +$34.2K 0.01% 1081
2024
Q3 		$74K Buy
623
+111
+22% +$10.2K 0.01% 1212
2024
Q2 		$41.1K Buy
512
+238
+87% +$21.8K 0.01% 1333
2024
Q1 		$25.3K Buy
274
+150
+121% +$14.4K 0.01% 1483
2023
Q4 		$11.8K Buy
+124
New +$12.5K ﹤0.01% 1818

Other funds holding BNTX

CCP
Crocodile Capital Partners Ursensollen, Germany $160M AUM 18.68% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

GAMMA Investing's BNTX Position: Q3 2026 in Review

GAMMA Investing increased its BioNTech (BNTX) stake by 14% in Q3 2026, buying an estimated $7.77K and bringing the position to 651 shares worth $64K. The position accounts for ﹤0.01% of the portfolio, ranked #2201.

GAMMA Investing first reported a position in BNTX in Q4 2023 and has held it in 12 quarters since. The position peaked at $105K in Q4 2024. 5 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.

  • GAMMA Investing held 651 shares of BioNTech worth $64K as of Q3 2026.
  • GAMMA Investing bought 80 BioNTech shares in Q3 2026, an estimated $7.77K.
  • BioNTech made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2201 holding.
  • GAMMA Investing first reported a position in BioNTech in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's BioNTech position peaked at $105K in Q4 2024.
  • 5 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.